You are here: Industry Insights > Market News > Moderna might manufacture COVID-19 vaccines in Japan

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

water filter

WATER FILTER FOR WATER PURIFIER

DUST BAG

Small dust filter

HUMIDIFIER FILTER

Oil fume adsorption filter

Moderna might manufacture COVID-19 vaccines in Japan

expresspharmaMay 24, 2021

Tag: Moderna , COVID-19 Vaccines , Japan

Favorites

Moderna Inc is considering manufacturing its COVID-19 vaccine in Japan, Nikkei newspaper reported, citing an interview with Stephane Bancel, the company’s CEO.

Moderna might manufacture COVID-19 vaccines in Japan

The company is looking into making the vaccine in Asia, including in Japan, Bancel told Nikkei.

Takeda Pharmaceutical in Japan has been handling importation and regulatory filing for the vaccine, which the health ministry officially approved today.

Previous:Morepen EGM approves Rs 433 crores investment from Corinth and promoters

Next:API market tested by COVID-19 but pandemic is accelerating adoption of supply chain solutions: CPhI panel

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

PharmaSourcesOctober 15, 2024

Thrombolytic Science, LLC (TSI), announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for mutant prourokinase, a recombinant fibrinolytic pro-enzyme.

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

PharmaSourcesOctober 15, 2024

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

PharmaSourcesOctober 15, 2024

Moderna might manufacture COVID-19 vaccines in Japan | Pharmasources.com

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

PharmaSourcesOctober 15, 2024

BD and ten23 health today announced a collaboration to develop a new way to track prefillable syringes (PFS) using RFID technology.

You may like
More>>

Gallic acid Japanese enterprise standard

Desiccant use Japanese Paper

Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Organic Matcha Tea Powder

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract Rotundine

Japanese Pagodatree Flower-bud

American standard Japanese standard German standard gate valve

Desiccants use Japanese papaer

Organic Ceremonial Green Japanese Face Instant Greentea Grade Halal Pure Oem Japan Matcha Tea Powder

Stephania japonica extract Japanese Stephania Root extract Tabellae Cepharanthini extract

PHENOXYMETHYL PENICILLIN POTASSIUM

Moderna might manufacture COVID-19 vaccines in Japan

Related News

Thrombolytic Science Announces FDA’s IND Clearance of Mutant Prourokinase for the Treatment of Thrombotic Diseases

Eleva Appoints Dr. Elisabeth Lackner to its Supervisory Board Adding Broad Biopharmaceutical Industry Expertise to the Organization

BrainDos™ Formulated Dual GIP/GLP-1 Receptor Agonist Tirzepatide Outperforms Tirzepatide Solution (Mounjaro®) in Preclinical Study

BD and ten23 health® Partner to Advance Efficiency and Quality in Aseptic Manufacturing with RFID-Enabled Prefillable Syringes

You may likeMore>>

You may like
More>>